+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Repurposing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 to 2033

  • PDF Icon

    Report

  • 186 Pages
  • October 2025
  • Region: Global
  • Acute Market Reports
  • ID: 6234395
Description Jump to:
The drug repurposing market grows at a 4.5% CAGR as sponsors use known safety profiles, real-world evidence, and computational screening to shorten timelines and reduce R&D risk across oncology, neurology/CNS, infectious, cardiovascular, and metabolic indications. Regulatory pathways (505(b)(2)/hybrid) and lifecycle strategies for off-patent assets support label expansions and fixed-dose combinations. Data integration from omics, target knowledge graphs, and AI-assisted similarity mapping improves hit triage and trial design. Within the base period, small-molecule programs contribute the highest revenue given a larger pool of legacy assets and established regulatory routes, while biologics are expected to record the highest CAGR as antibody, enzyme, and RNA-based candidates are repositioned using biomarker-guided evidence.

Market Drivers

The model benefits from lower development cost versus de-novo discovery, faster Phase I/II progression due to existing safety data, and payer interest in proven mechanisms for unmet needs. Growth is reinforced by real-world datasets, biobank access, and adaptive platform trials that compress time to proof-of-concept. Partnerships between pharma, AI-native biotechs, and academic translational centers expand asset libraries and in-silico hypothesis generation.

Market Restraints

IP complexity, data exclusivity limitations, and competitive generics can reduce upside for older molecules. Heterogeneous evidence quality and limited disease-specific biomarkers increase failure risk in late phase. Indication switching may face pricing and reimbursement hurdles without robust outcomes data. Operationally, sourcing clinical-grade supply for discontinued molecules and aligning global regulatory strategies lengthen timelines for multi-region launches.

Segmentation by Drug Type - Small Molecules, Biologics

Small molecules anchor current revenue because they dominate legacy pipelines, have well-characterized ADME/safety, and fit established 505(b)(2) or equivalent pathways with scalable CMC and cost of goods; within drug types this segment generates the highest revenue. Biologics (antibodies, peptides, enzymes, nucleic acid-based modalities) expand faster as biomarker-defined cohorts and precision imaging support signal detection in smaller trials; within drug types biologics are expected to post the highest CAGR as sponsors reposition immune and inflammation assets into oncology, neurodegeneration, and rare diseases.

Segmentation by Therapeutic Area - Oncology, Neurology & CNS, Infectious, Cardiovascular, Metabolic, Others

Oncology delivers the largest revenue due to high trial activity, basket/umbrella designs, and pricing headroom for label extensions; within therapeutic areas oncology generates the highest revenue. Neurology and CNS disorders are expected to record the highest CAGR as repurposed anti-inflammatory, metabolic, and synaptic-modulating agents move into Alzheimer's, Parkinson's, ALS, and neuropathic pain with biomarker-guided endpoints. Infectious diseases maintain steady demand for host-directed therapies and antivirals with pandemic preparedness value. Cardiovascular and metabolic disorders focus on pleiotropic effects (anti-inflammatory, GLP-1 axis, lipid modulation) to broaden labels. "Other" areas include dermatology, rheumatology, ophthalmology, and rare diseases where small, biomarker-rich cohorts support rapid PoC.

Regional Insights

North America leads near-term revenue given strong 505(b)(2) utilization, deep real-world data assets, and active venture formation. Europe advances via hybrid pathways, public-private consortia, and hospital-led repurposing initiatives. Asia-Pacific shows rising activity with expanding hospital networks, genomic programs, and cost-efficient trial execution; the region is expected to post a solid growth rate as precision-medicine infrastructure scales. Latin America and the Middle East & Africa are earlier in adoption, with growth linked to government-backed trials and access initiatives.

Competitive Landscape

Large pharma and AI-native biotech form a two-track landscape. AbbVie, Amgen, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Novartis, Pfizer, and Sanofi drive revenue through portfolio pruning, life-cycle extensions, and in-licensing of de-risked assets. Recursion Pharmaceuticals, Valence Discovery, Cyclica, and Revolution Medicines apply ML-driven mapping, phenomics, and structure-based approaches to identify new indications and prioritize trial designs. Pharnext and Melior Discovery specialize in network pharmacology and clinical repositioning platforms. Schwarz Pharma contributes legacy CNS and cardiovascular assets within broader portfolios. Sponsors with broad data access, clear IP strategy, and integrated CMC/clinical capabilities hold the largest revenue today, while AI-enabled discovery platforms and biomarker-rich CNS/rare disease programs are positioned for the highest CAGR.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions & recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Drug Repurposing market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users & consumption volume, price, and value.
  • Geographical revenues generated by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Drug Repurposing market and their expected impact during the forecast period.
The market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

  • Drug Type
    • Small molecules
    • Biologics

  • Therapeutic Area
    • Oncology
    • Neurology and CNS disorders
    • Infectious diseases
    • Cardiovascular diseases
    • Metabolic disorders
    • Other therapeutic areas

  • Route of Administration
    • Oral
    • Intravenous
    • Other routes of administration

  • End Use
    • Pharmaceutical and biopharmaceutical companies
    • Contract Research Organization (CROs)
    • Other end use

Region Segment (2023 - 2033; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Drug Repurposing market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Drug Repurposing market?
  • Which is the largest regional market for Drug Repurposing market?
  • What are the market trends and dynamics in emerging markets such as Asia-Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Drug Repurposing market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Drug Repurposing market worldwide?

This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Drug Repurposing Market
2.2. Global Drug Repurposing Market, by Drug Type, 2024 (US$ Million)
2.3. Global Drug Repurposing Market, by Therapeutic Area, 2024 (US$ Million)
2.4. Global Drug Repurposing Market, by Route of Administration, 2024 (US$ Million)
2.5. Global Drug Repurposing Market, by End Use, 2024 (US$ Million)
2.6. Global Drug Repurposing Market, by Geography, 2024 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2024
3. Drug Repurposing Market: Competitive Analysis
3.1. Market Positioning of Key Drug Repurposing Market Vendors
3.2. Strategies Adopted by Drug Repurposing Market Vendors
4. Drug Repurposing Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Drug Repurposing Market Value, 2023-2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape
5. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Small molecules
5.3.2. Biologics       Â
6. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Oncology
6.3.2. Neurology and CNS disorders
6.3.3. Infectious diseases
6.3.4. Cardiovascular diseases
6.3.5. Metabolic disorders
6.3.6. Other therapeutic areas
7. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2024 Versus 2033
7.3. Market Segmentation
7.3.1. Oral
7.3.2. Intravenous
7.3.3. Other routes of administration
8. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2024 Versus 2033
8.3. Market Segmentation
8.3.1. Pharmaceutical and biopharmaceutical companies
8.3.2. Contract Research Organization (CROs)
8.3.3. Other end use
9. North America Drug Repurposing Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
9.3. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
9.4. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
9.5. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
9.6. Drug Repurposing Market: by Region, 2023-2033, USD (Million)
9.6.1. North America
9.6.1.1. U.S.
9.6.1.1.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
9.6.1.1.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
9.6.1.1.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
9.6.1.1.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
9.6.1.2.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
9.6.1.2.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
9.6.1.2.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
9.6.1.3.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
9.6.1.3.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
9.6.1.3.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
10. UK and European Union Drug Repurposing Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
10.3. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
10.4. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
10.5. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
10.6. Drug Repurposing Market: by Region, 2023-2033, USD (Million)
10.6.1. UK and European Union
10.6.1.1. UK
10.6.1.1.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
10.6.1.1.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
10.6.1.1.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
10.6.1.1.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
10.6.1.2.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
10.6.1.2.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
10.6.1.2.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
10.6.1.3.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
10.6.1.3.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
10.6.1.3.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
10.6.1.4.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
10.6.1.4.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
10.6.1.4.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
10.6.1.5. France
10.6.1.5.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
10.6.1.5.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
10.6.1.5.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
10.6.1.5.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
10.6.1.6.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
10.6.1.6.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
10.6.1.6.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
11. Asia-Pacific Drug Repurposing Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
11.3. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
11.4. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
11.5. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
11.6. Drug Repurposing Market: by Region, 2023-2033, USD (Million)
11.6.1. Asia-Pacific
11.6.1.1. China
11.6.1.1.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
11.6.1.1.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
11.6.1.1.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
11.6.1.1.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
11.6.1.2.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
11.6.1.2.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
11.6.1.2.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
11.6.1.3. India
11.6.1.3.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
11.6.1.3.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
11.6.1.3.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
11.6.1.3.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
11.6.1.4.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
11.6.1.4.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
11.6.1.4.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
11.6.1.5.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
11.6.1.5.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
11.6.1.5.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
11.6.1.6. Rest of Asia-Pacific
11.6.1.6.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
11.6.1.6.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
11.6.1.6.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
11.6.1.6.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
12. Latin America Drug Repurposing Market, 2023-2033, USD (Million)
12.1. Market Overview
12.2. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
12.3. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
12.4. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
12.5. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
12.6. Drug Repurposing Market: by Region, 2023-2033, USD (Million)
12.6.1. Latin America
12.6.1.1. Brazil
12.6.1.1.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
12.6.1.1.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
12.6.1.1.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
12.6.1.1.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
12.6.1.2.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
12.6.1.2.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
12.6.1.2.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
12.6.1.3.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
12.6.1.3.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
12.6.1.3.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
13. Middle East and Africa Drug Repurposing Market, 2023-2033, USD (Million)
13.1. Market Overview
13.2. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
13.3. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
13.4. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
13.5. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
13.6. Drug Repurposing Market: by Region, 2023-2033, USD (Million)
13.6.1. Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
13.6.1.1.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
13.6.1.1.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
13.6.1.1.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
13.6.1.2.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
13.6.1.2.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
13.6.1.2.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Drug Repurposing Market: by Drug Type, 2023-2033, USD (Million)
13.6.1.3.2. Drug Repurposing Market: by Therapeutic Area, 2023-2033, USD (Million)
13.6.1.3.3. Drug Repurposing Market: by Route of Administration, 2023-2033, USD (Million)
13.6.1.3.4. Drug Repurposing Market: by End Use, 2023-2033, USD (Million)
14. Company Profiles
14.1. AbbVie
(Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
14.2. Amgen
14.3. Boehringer Ingelheim
14.4. Cyclica
14.5. Eli Lilly and Company
14.6. GlaxoSmithKline
14.7. Melior Discovery
14.8. Novartis
14.9. Pfizer
14.10. Pharnext
14.11. Recursion Pharmaceuticals
14.12. Revolution Medicines
14.13. Sanofi
14.14. Schwarz Pharma
14.15. Other Notable Players
List of Tables
Table 1 Global Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 2 Global Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 3 Global Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 4 Global Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 5 North America Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 6 North America Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 7 North America Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 8 North America Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 9 U.S. Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 10 U.S. Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 11 U.S. Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 12 U.S. Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 13 Canada Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 14 Canada Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 15 Canada Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 16 Canada Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 17 Rest of North America Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 18 Rest of North America Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 19 Rest of North America Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 20 Rest of North America Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 21 UK and European Union Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 22 UK and European Union Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 23 UK and European Union Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 24 UK and European Union Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 25 UK Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 26 UK Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 27 UK Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 28 UK Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 29 Germany Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 30 Germany Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 31 Germany Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 32 Germany Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 33 Spain Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 34 Spain Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 35 Spain Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 36 Spain Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 37 Italy Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 38 Italy Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 39 Italy Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 40 Italy Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 41 France Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 42 France Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 43 France Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 44 France Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 45 Rest of Europe Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 46 Rest of Europe Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 47 Rest of Europe Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 48 Rest of Europe Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 49 Asia Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 50 Asia Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 51 Asia Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 52 Asia Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 53 China Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 54 China Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 55 China Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 56 China Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 57 Japan Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 58 Japan Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 59 Japan Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 60 Japan Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 61 India Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 62 India Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 63 India Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 64 India Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 65 Australia Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 66 Australia Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 67 Australia Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 68 Australia Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 69 South Korea Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 70 South Korea Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 71 South Korea Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 72 South Korea Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 73 Latin America Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 74 Latin America Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 75 Latin America Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 76 Latin America Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 77 Brazil Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 78 Brazil Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 79 Brazil Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 80 Brazil Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 81 Mexico Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 82 Mexico Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 83 Mexico Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 84 Mexico Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 85 Rest of Latin America Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 86 Rest of Latin America Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 87 Rest of Latin America Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 88 Rest of Latin America Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 89 Middle East and Africa Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 90 Middle East and Africa Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 91 Middle East and Africa Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 92 Middle East and Africa Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 93 GCC Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 94 GCC Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 95 GCC Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 96 GCC Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 97 Africa Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 98 Africa Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 99 Africa Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 100 Africa Drug Repurposing Market by End Use, 2023-2033, USD (Million)
Table 101 Rest of Middle East and Africa Drug Repurposing Market by Drug Type, 2023-2033, USD (Million)
Table 102 Rest of Middle East and Africa Drug Repurposing Market by Therapeutic Area, 2023-2033, USD (Million)
Table 103 Rest of Middle East and Africa Drug Repurposing Market by Route of Administration, 2023-2033, USD (Million)
Table 104 Rest of Middle East and Africa Drug Repurposing Market by End Use, 2023-2033, USD (Million)
List of Figures
Figure 1 Global Drug Repurposing Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Drug Repurposing Market: Quality Assurance
Figure 5 Global Drug Repurposing Market, by Drug Type, 2024
Figure 6 Global Drug Repurposing Market, by Therapeutic Area, 2024
Figure 7 Global Drug Repurposing Market, by Route of Administration, 2024
Figure 8 Global Drug Repurposing Market, by End Use, 2024
Figure 9 Global Drug Repurposing Market, by Geography, 2024
Figure 10 Market Geographical Opportunity Matrix - Global Drug Repurposing Market, 2024
Figure 11 Market Positioning of Key Drug Repurposing Market Players, 2024
Figure 12 Global Drug Repurposing Market, by Drug Type, 2024 Vs 2033, %
Figure 13 Global Drug Repurposing Market, by Therapeutic Area, 2024 Vs 2033, %
Figure 14 Global Drug Repurposing Market, by Route of Administration, 2024 Vs 2033, %
Figure 15 Global Drug Repurposing Market, by End Use, 2024 Vs 2033, %
Figure 16 U.S. Drug Repurposing Market (US$ Million), 2023-2033
Figure 17 Canada Drug Repurposing Market (US$ Million), 2023-2033
Figure 18 Rest of North America Drug Repurposing Market (US$ Million), 2023-2033
Figure 19 UK Drug Repurposing Market (US$ Million), 2023-2033
Figure 20 Germany Drug Repurposing Market (US$ Million), 2023-2033
Figure 21 Spain Drug Repurposing Market (US$ Million), 2023-2033
Figure 22 Italy Drug Repurposing Market (US$ Million), 2023-2033
Figure 23 France Drug Repurposing Market (US$ Million), 2023-2033
Figure 24 Rest of Europe Drug Repurposing Market (US$ Million), 2023-2033
Figure 25 China Drug Repurposing Market (US$ Million), 2023-2033
Figure 26 Japan Drug Repurposing Market (US$ Million), 2023-2033
Figure 27 India Drug Repurposing Market (US$ Million), 2023-2033
Figure 28 Australia Drug Repurposing Market (US$ Million), 2023-2033
Figure 29 South Korea Drug Repurposing Market (US$ Million), 2023-2033
Figure 30 Rest of Asia Drug Repurposing Market (US$ Million), 2023-2033
Figure 31 Brazil Drug Repurposing Market (US$ Million), 2023-2033
Figure 32 Mexico Drug Repurposing Market (US$ Million), 2023-2033
Figure 33 Rest of Latin America Drug Repurposing Market (US$ Million), 2023-2033
Figure 34 GCC Drug Repurposing Market (US$ Million), 2023-2033
Figure 35 Africa Drug Repurposing Market (US$ Million), 2023-2033
Figure 36 Rest of Middle East and Africa Drug Repurposing Market (US$ Million), 2023-2033

Companies Mentioned

  • AbbVie
  • Amgen
  • Boehringer Ingelheim
  • Cyclica
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Melior Discovery
  • Novartis
  • Pfizer
  • Pharnext
  • Recursion Pharmaceuticals
  • Revolution Medicines
  • Sanofi
  • Schwarz Pharma

Related Topics

Related Reports

Drug Repurposing Market Forecast to 2033 - Product Image

Drug Repurposing Market Forecast to 2033

  • Report
  • 150 Pages
  • Global
From
Artificial Intelligence in Drug Repurposing Market Size, Share & Trends Analysis Report by Component, Technology, Application, End Use, and Region with Growth Forecasts, 2026-2033 - Product Image

Artificial Intelligence in Drug Repurposing Market Size, Share & Trends Analysis Report by Component, Technology, Application, End Use, and Region with Growth Forecasts, 2026-2033

  • Report
  • 100 Pages
  • Global
From
Artificial Intelligence in Drug Discovery Market Size, Share & Trends Analysis Report by Application, Therapeutic Area, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Artificial Intelligence in Drug Discovery Market Size, Share & Trends Analysis Report by Application, Therapeutic Area, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 100 Pages
  • Global
From
Drug Repurposing Market Report 2026 - Product Image

Drug Repurposing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Drug Repurposing Market - Global Strategic Business Report - Product Image

Drug Repurposing Market - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.